Saudi Journal of Medicine & Medical Sciences

Saudi Journal of Medicine & Medical Sciences is the official scientific journal of Imam Abdulrahman Bin Faisal University in Dammam, Saudi Arabia, and Wolters Kluwer Medknow publishes it on the university's behalf. It has appeared in print and online since 2013 and covers general medicine together with the wider health sciences. The 2025 Journal Citation Reports place it in the second quartile of general and internal medicine, with an impact factor of 2.4.《沙特医学与医学科学杂志》是沙特阿拉伯达曼伊玛目阿卜杜勒拉赫曼·本·费萨尔大学的官方学术期刊，由 Wolters Kluwer Medknow 代表校方出版。该刊 2013 年起以印刷版与网络版并行发行，内容覆盖普通医学以及更广泛的健康科学。2025 年期刊引证报告把它列入普通与内科学类别的第二四分位，影响因子为 2.4。

Scope

• The journal calls itself a peer-reviewed general medical journal, and its stated scope is research that matters to health specialties in academic work and in clinical practice alike.该刊自述为一份经同行评审的普通医学期刊，申明的范围是对学术研究与临床实践中的各健康专业都有意义的研究。

• The purpose set out for the title is to promote excellence in the practice of medicine and medical health sciences and to spread knowledge, attitudes and practice across comprehensive care.刊物为自身设定的宗旨是促进医学与医学卫生科学的卓越实践，并在综合照护中传播知识，态度与技能。

• Preventive, curative and rehabilitative care all sit inside that remit, and medical research, medical education and health services are treated as parts of one enterprise.预防，治疗与康复三类照护都在这条轨道之内，医学研究，医学教育与卫生服务被视为同一项事业的组成部分。

• Readers are expected from every branch of the health cluster, among them medicine, dentistry, nursing, applied medical sciences, clinical pharmacology and public health.读者对象覆盖健康集群的每一个分支，其中有医学，牙科，护理，应用医学科学，临床药理学与公共卫生。

• Original papers, systematic and narrative reviews, brief reports and letters to the editor are all welcomed, and case reports enter consideration when they carry substantial clinical significance.原创论文，系统综述与叙述性综述，简报以及致编辑的信都在欢迎之列，具有重要临床价值的病例报告也可进入审稿程序。

• Editorials are commissioned by the editors, and the greater part of each issue still comes from authors who send their work without an invitation.社论由编辑部约稿，每一期的大部分内容仍来自作者主动投寄的稿件。

• Clinical medicine forms the core, with the board drawn from gastroenterology, hepatology, anaesthesiology, pulmonology, nephrology, cardiology, radiology, pathology and surgery.临床医学构成核心，编委队伍来自胃肠病学，肝病学，麻醉学，呼吸病学，肾脏病学，心脏病学，放射学，病理学与外科学。

• Paediatrics and child health, medical genetics, clinical pharmacology and pharmacy, biostatistics and behavioural science appear among the specialties that the editors represent.儿科与儿童健康，医学遗传学，临床药理学与药学，生物统计学与行为科学同样属于编委所代表的专业。

• Dentistry and the applied medical sciences enter through the university's health cluster, which contributes prosthodontics, microbiology and laboratory disciplines to the board.牙科与应用医学科学经由大学的健康集群纳入范围，口腔修复学，微生物学与实验室学科由此进入编委名单。

• Medical education is accepted in the same formats as original and review articles, so studies of how doctors and other health professionals are trained have a home here.医学教育类稿件按原创论文与综述的同一体例接收，讨论医师及其他卫生专业人员培养方式的研究因此有处可投。

• Systematic reviews with meta-analysis must carry a structured abstract and follow PRISMA or MOOSE, and prospective registration in PROSPERO is preferred rather than demanded.带荟萃分析的系统综述须附结构式摘要并遵循 PRISMA 或 MOOSE，刊物希望作者事先在 PROSPERO 注册研究方案，此事只是提倡，并不强制。

• Original articles run to 3000 words, brief reports to 1200, case reports to 1500 and letters to 500, while abstracts stop at 250 words.原创论文正文以 3000 词为限，简报 1200 词，病例报告 1500 词，致编辑的信 500 词，摘要一律不超过 250 词。

• Each abstract is structured under Background, Objectives, Materials or Patients and methods, Results and Conclusion, and at least three keywords follow in alphabetical order.每篇摘要都按背景，目的，材料或患者与方法，结果，结论五个小标题排列，其后附至少 3 个按字母顺序排列的关键词。

• Short commentary under the In Focus label is taken up to 500 words and five references, and study reports must arrive with the matching checklist, among them CONSORT, STROBE, PRISMA and CARE.刊物另收 In Focus 栏目的短评，篇幅不超过 500 词并附 5 条参考文献，研究报告须随稿提交相应的清单，例如 CONSORT，STROBE，PRISMA 与 CARE。

History

• Volume 1 is dated 2013, the first year in the National Library of Medicine record, and the imprint has stayed with Wolters Kluwer Medknow in Mumbai.第 1 卷标注为 2013 年，这也是美国国家医学图书馆记录中的起始年份，出版印记一直落在孟买的 Wolters Kluwer Medknow。

• Imam Abdulrahman Bin Faisal University in Dammam sponsors the title, and the journal serves as the scientific record of a university with colleges of medicine, dentistry and applied medical sciences.达曼的伊玛目阿卜杜勒拉赫曼·本·费萨尔大学为刊物提供赞助，校内设有医学院，牙科学院与应用医学科学学院，该刊则充任这所大学的学术记录。

• Medknow, the publishing arm, was founded in 1997 and sits inside Wolters Kluwer Health, and its list carries more than 450 medical journals.出版方 Medknow 创办于 1997 年，隶属 Wolters Kluwer Health，旗下医学期刊超过 450 种。

• Print and online editions have run in parallel since the launch, and authors may archive the accepted version in any repository that complies with the Open Archives Initiative.印刷版与网络版自创刊起并行出版，作者可以把录用稿自存到任何符合开放档案倡议的机构库或学科库。

• PubMed coverage began with volume 4, issue 1, in 2016, and the full text is deposited in PubMed Central as well.PubMed 的收录自 2016 年第 4 卷第 1 期开始，全文同时存入 PubMed Central。

• The title also appears in the Emerging Sources Citation Index, Scopus, DOAJ, EMBASE and EMR Index Medicus, and abstracting services such as EBSCO and ProQuest carry its contents.该刊还见于新兴来源引文索引，Scopus，DOAJ，EMBASE 与 EMR Index Medicus，EBSCO 与 ProQuest 等文摘服务也转录其内容。

• For a stretch the journal appeared three times a year, the pattern that the NLM catalogue records from 2014, and publication is now quarterly with four issues to a volume.有一段时期刊物每年出版 3 期，国家医学图书馆的目录从 2014 年起如此记载，如今出版节奏改为季刊，每卷 4 期。

• Volume 14, issue 4, dated October to December 2026, marks the present quarterly rhythm, and the volume number has risen by one each year since 2013.第 14 卷第 4 期标注 2026 年 10 月至 12 月，正合当下的季刊节奏，卷号自 2013 年起每年递增一卷。

• The journal calls itself a diamond, or platinum, open access title, and no fee is charged for submission, processing, colour reproduction or publication.刊物自称钻石开放获取，也称白金开放获取，投稿，处理，彩图制版与发表均不收取任何费用。

• Articles are distributed under a Creative Commons Attribution NonCommercial NoDerivatives 4.0 licence, which allows copying and redistribution for non-commercial use without adaptation.文章按知识共享署名非商业性禁止演绎 4.0 国际许可协议分发，允许在非商业前提下复制与再分发，但不得改编。

• Accepted papers appear online ahead of print under a DOI, and the publisher treats those versions as citable records that change only through published errata.录用稿件先以数字对象标识符在线预出版，出版方把这些版本视为可引用的正式记录，日后只通过公开勘误加以更正。

• Long-term preservation rests on Portico and CLOCKSS, two archival services that keep the content available if the journal or its platform stops operating.长期保存依托 Portico 与 CLOCKSS 两项存档服务，即使刊物或其平台停止运营，内容仍可调取。

• Advertising pays for the free-to-read model, the slots rotate without the advertiser choosing pages, and the editorial board holds final approval over what runs.广告收入支撑免费阅读模式，广告位随机轮播且广告主不能指定页面，内容由编委会最终审定。

• The impact factor rose from 1.3 in 2023 to 1.5 in 2024 and 2.4 in 2025, and the 2025 Journal Citation Reports rank the title 94th among 336 journals in general and internal medicine.影响因子从 2023 年的 1.3 升至 2024 年的 1.5，2025 年为 2.4，2025 年期刊引证报告在普通与内科学 336 种期刊中把它排在第 94 位。

Editors

• Abdulaziz A Al-Quorain, professor of gastroenterology and hepatology at the College of Medicine of Imam Abdulrahman Bin Faisal University, is editor-in-chief.主编为（Abdulaziz A Al-Quorain），他是伊玛目阿卜杜勒拉赫曼·本·费萨尔大学医学院的胃肠病学与肝病学教授。

• Amein K Al-Ali, professor of biochemistry in the same college, is an associate editor, and Nasreldin Elhadi, professor of microbiology in the College of Applied Medical Sciences, holds the same rank.副编辑包括（Amein K Al-Ali）与（Nasreldin Elhadi），前者为该校医学院生物化学教授，后者为应用医学科学学院微生物学教授。

• Mohamed R El Tahan is the third associate editor, professor of anaesthesiology at Mansoura University in Egypt and associate professor at the Dammam college.第三位副编辑是（Mohamed R El Tahan），他在埃及曼苏拉大学任麻醉学教授，同时在达曼的医学院任麻醉学副教授。

• The masthead lists two assistant editors, Ansaf K Shaikh and Anas Abdul Salam, both lecturers at the university in Dammam.编务名单另列两位助理编辑（Ansaf K Shaikh）与（Anas Abdul Salam），二人都是达曼这所大学的讲师。

• The editorial board proper has 26 members, and the sponsoring university supplies its core, among them Abdullah M Al-Rubaish in pulmonology, Fahad A Al-Harbi in prosthodontics, Abdullah Abdulsalam Yousef in paediatrics and Fahad A Al-Muhanna in nephrology.编委会本身有 26 位成员，主力来自主办大学，包括呼吸病学的（Abdullah M Al-Rubaish），口腔修复学的（Fahad A Al-Harbi），儿科学的（Abdullah Abdulsalam Yousef）与肾脏病学的（Fahad A Al-Muhanna）。

• Five members work in the United States, among them Alexander F Norbash and Karen H Antman of Boston University, Mohamed O Othman of Baylor College of Medicine and Ronald See of Westmont College.五位编委在美国任职，其中有波士顿大学的（Alexander F Norbash）与（Karen H Antman），贝勒医学院的（Mohamed O Othman）以及韦斯特蒙特学院的（Ronald See）。

• The Netherlands contributes Bobby P.C. Koeleman in medical genetics and Folker W Asselbergs in cardiology at the University of Utrecht, while Canada fields Daniel S Sitar, David Kendler and Roman Jaeschke.荷兰方面有乌得勒支大学医学遗传学的（Bobby P.C. Koeleman）与心脏病学的（Folker W Asselbergs），加拿大方面则有（Daniel S Sitar），（David Kendler）与（Roman Jaeschke）。

• Sitar is emeritus at the University of Manitoba, Kendler teaches endocrinology at the University of British Columbia and Jaeschke works in clinical epidemiology and biostatistics at McMaster University.其中（Daniel S Sitar）为曼尼托巴大学荣休教授，（David Kendler）在不列颠哥伦比亚大学讲授内分泌学，临床流行病学与生物统计学则由麦克马斯特大学的（Roman Jaeschke）承担。

• Britain adds Ram Bajpai in biostatistics at Keele University and Satyajit Sarker in pharmacy at Liverpool John Moores University, and Ireland supplies Marie Greally and Noel G McElvaney.英国方面有基尔大学生物统计学的（Ram Bajpai）与利物浦约翰摩尔斯大学药学的（Satyajit Sarker），爱尔兰方面则有（Marie Greally）与（Noel G McElvaney）。

• Single seats come from France, Greece, Australia and Korea, filled by Laurent Peyrin-Biroulet in inflammatory bowel disease, Grigoris Stratakos in respiratory medicine, Adam Jaffe and Stephen Jane in child health and medicine, and Sung Hoon Noh in surgery.法国，希腊，澳大利亚与韩国各有一席，依次为炎症性肠病方向的（Laurent Peyrin-Biroulet），呼吸医学的（Grigoris Stratakos），儿童健康与内科学的（Adam Jaffe）与（Stephen Jane），以及外科学的（Sung Hoon Noh）。

• Three more board members sit at other Saudi institutions, Abed Al-Lehibi at King Saud Bin Abdulaziz University for Health Sciences, Waleed A Milaat at King Abdulaziz University and Mohammadd I. El Mouzan at King Saud University.另有三位编委来自沙特的其他机构，分别是沙特本阿卜杜勒阿齐兹健康科学大学的（Abed Al-Lehibi），阿卜杜勒阿齐兹国王大学的（Waleed A Milaat）与沙特国王大学的（Mohammadd I. El Mouzan）。

• Review is double blind, and each manuscript passes iThenticate screening and an internal read before at least two independent external experts assess the science.评审实行双盲，每篇稿件先经 iThenticate 查重与编辑部内审，再由至少 2 位独立外审专家评判学术质量。

• The editor-in-chief takes the final decision on the strength of the reports, and authors who revise answer each comment point by point until the reviewers are satisfied.主编依据审稿意见作出终裁，需要修回的作者须逐条答复，直到审稿人与编辑认可为止。

• Manuscripts from the sponsoring university follow a recusal rule, so no reviewer shares the authors' institution, board members from that university leave the process and the editor-in-chief withdraws from the final decision.来自主办大学的稿件另有一套回避规则，审稿人不与作者同属一个机构，该校编委退出全部流程，主编本人也不参与终裁。

• Papers written by board members are screened by the editor-in-chief and sent for external review, and the authors' colleagues on the board take no part in the decision.编委署名的稿件由主编初筛后送外审，与作者同列的编委不参与任何决定。

• Authors who think a rejection was wrong may appeal within six to eight weeks, a second appeal is not accepted, and complaints are answered within two to four weeks.作者若认为拒稿有误可在 6 至 8 周内提出申诉，刊物不接受二次申诉，投诉一般在 2 至 4 周内答复。

• The journal follows ICMJE, COPE and WAME guidance, and trials must be registered in a freely accessible register such as ClinicalTrials.gov, ISRCTN, UMIN-CTR or CTRI for studies that began enrolment from June 2018.刊物遵循 ICMJE，COPE 与 WAME 的指南，自 2018 年 6 月起开始入组的临床试验须在 ClinicalTrials.gov，ISRCTN，UMIN-CTR 或 CTRI 等可免费公开访问的平台完成注册。